🚀 AI vs. Thrombosis Experts: Who performs better?

New study shows: AI models deliver patient education answers that are often rated better than experts — and perform similar in complex clinical cases.

@nikola-vladic.bsky.social @jeanconnorsmd.bsky.social @jthjournal.bsky.social

Our Annual Congress Planning Committee (ACPC) is hard at work in Paris this week, laying the groundwork for an unforgettable #ISTH2026! The best is yet to come! Learn more here: www.isthcongress.org

Really great state-of-the-art talk by Julia Riedl on the role of podoplanin in brain cancer-assiciated thrombosis #ISTH2025

It’s really worth stopping by our @isth.org booth and get inspired for next year’s meeting in….. Paris!

#ISTH2025

Great work by Hoberstorfer from Vienna 👏Unfortunately, machine learning of #cancer-associated thrombosis prediction didn’t outperform current models. Showing how complex CAT is #ISTH2025 @cihanaymd.bsky.social

Check out the late-breakthrough abstracts - featuring cutting-edge data from major clinical trials & game-changing studies - to be presented at the @ISTH.org #ISTH2025 congress starting on June 21.
It is not too late to register and participate in person or on-demand!
Learn more: bit.ly/4jI5oDL

Introducing: The ISTH Congress Attendee Starter Pack loaded with essentials for an epic #ISTH2025, including:
✅Endless enthusiasm from @guyyoungmd.bsky.social
✅A refillable coffee cup
✅A tote bag stuffed with 17 pens
Register now: www.isth2025.org and tell us what’s a must-have in your starter pack?

Big congrats to Stephan Nopp on his successful PhD defense! 🎓👏
It was a real pleasure working with you – smart, dedicated, and a true team player. Wishing you all the best for what’s next!

We have successfully treated the first patient with #hemophilia B in Austria at the beginning of April - truly a "game changer" for people with hemophilia. Grateful to live in a country where innovative treatments like this are accessible, offering new hope for the future.

@acc25.bsky.social Isabelle Mahe presents API-CAT
Low dose Apixaban noninferior to high dose for recurrent VTE and superior for lower bleeding-another win!

Prof. @isabellemahe.bsky.social presents API-CAT at @accintouch.bsky.social published in @nejm.org: Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in cancer patients
www.nejm.org/doi/full/10....

📢 @jthjournal.bsky.social is proud to announce the recipients of the 2025 JTH Editors’ Awards!

These prestigious awards honor six outstanding early career investigators for their top articles in thrombosis and hemostasis. Join us in congratulating the winners🎉 and learn more here: bit.ly/4lc2pFR

Postpartum hemorrhage is a significant risk for many women yet the etiology is not well understood. New study from Claire de Moreuil shows that plasma from PPH have a different fibrin network than controls.
www.rpthjournal.org/article/S247...
@aswolberg.bsky.social @cihanaymd.bsky.social

Exited to share our latest research on biological aging in #hemophilia, an inherited bleeding disorder with significant improvements in life expectancy over the last decades.
Our results indicate an accelerated biological aging in people with hemophilia.
Access to paper: doi.org/10.3324/haem...

Air pollution and venous thromboembolism
Our commentary on the study published by Dr. Lutsey et al. in @bloodjournal.bsky.social reporting that greater long-term exposure to air pollution is associated with higher risk of developing VTE. doi.org/10.1182/bloo...

ashpublications.org/blood/articl...

📰 New article available #openaccess

Acute pulmonary embolism in children and adolescents in the USA (2016 and 2019): a nationwide retrospective cohort study

Acute pulmonary embolism is rare during childhood and adolescence

@mainzuniversity.bsky.social @cihanaymd.bsky.social

tinyurl.com/2avwapcr

Updates on risk assessment and prevention of cancer-associated #thrombosis in ambulatory patients with #cancer. Excellent overview in a State-of-the-Art Review by
@nikola-vladic.bsky.social published in @rpth.bsky.social @worldthrombosisday.bsky.social www.rpthjournal.org/article/S247...

Great idea. Thanks. I follow all on the list with one click only 😊

End-of-the-year get-together at the Christmas dinner/party of our Thrombosis and Haemostasis Research Group in Vienna.
Happy, proud & grateful what the team has achieved this year with many contributions to science & education.
Thank you to each team member - looking forward to continue our work!